Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
Anne Puel(Université Paris Cité), Jean‐Laurent Casanova(Howard Hughes Medical Institute)
Cited by 720
Related Papers
Gain-of-function human <i>STAT1</i> mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis
|The Journal of Experimental Medicine|2011|797
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
|The Journal of Experimental Medicine|2021|236
Novel STAT1 Alleles in Otherwise Healthy Patients with Mycobacterial Disease
|PLoS Genetics|2006|189
The human CIB1–EVER1–EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses
|The Journal of Experimental Medicine|2018|123
Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency
|Nature Immunology|2018|115